However, we found the association between low ING4 expression and high levels of p-p65/RelA in all tumors regardless of the HER2 status, suggesting that ING4 down-regulation may represent a mechanism of NF-κB activation independent of HER2/neu receptor signaling in breast cancer. Here, ING4 is linked to breast cancer.